Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5573633 | 0.90 | CHRM2 (0.60) | CYP1A2CYP2D6ALDH1A1CYP2C19HRH3 | |
| SCHEMBL29761156 | 0.87 | CHRM2 (0.66) | ALDH1A1KDM4EALOX15LMNATDP1 | |
| SCHEMBL5707323 | 0.87 | CYP1A2 (0.60) | CYP1A2CYP2D6ALDH1A1CYP2C19GAA | |
| SCHEMBL6322772 | 0.87 | BCHE (0.72) | ALDH1A1MEN1KMT2A | |
| SCHEMBL1392847 | 0.87 | CHRM2 (0.70) | CYP1A2CYP2D6ALDH1A1CYP2C19HRH3 | |
| SCHEMBL2854495 | 0.87 | KDM4E (0.59) | CYP1A2CYP2D6ALDH1A1CYP2C19HRH3 | |
| SCHEMBL2854302 | 0.87 | CYP1A2 (0.56) | CYP1A2CYP2D6ALDH1A1CYP2C19HRH3 | |
| SCHEMBL6832167 | 0.87 | CYP1A2 (0.55) | CYP1A2CYP2D6ALDH1A1CYP2C19HRH3 | |
| SCHEMBL5575878 | 0.85 | KDM4E (0.66) | CYP1A2CYP2D6ALDH1A1CYP2C19HRH3 | |
| SCHEMBL30338402 | 0.85 | KDM4E (0.66) | CYP1A2CYP2D6ALDH1A1CYP2C19HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210840-A1 | BACTERIAL NITRIC OXIDE SYNTHASE INHIBITORS | NORTHWESTERN UNIVERSITY | 2023-07-06 | — | — | US | disclosed |
| EP-3363288-B1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR MOSSES | CUREARTH INC (KR) | 2022-09-07 | — | — | EP | disclosed |
| CN-108347925-B | Compositions for destroying microalgae or moss | 株式会社CUREARTH | 2021-07-16 | — | — | CN | disclosed |
| US-11044909-B2 | Composition for destruction of microalgae or sphaerocarpus | CUREARTH, INC. (KR) | 2021-06-29 | — | — | US | disclosed |
| US-11044909-B2 | Composition for destruction of microalgae or sphaerocarpus | CUREARTH, INC. (KR) | 2021-06-29 | — | — | US | disclosed |
| US-20180271091-A1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR SPHAEROCARPUS | CUREARTH, INC. (KR) | 2018-09-27 | — | — | US | disclosed |
| EP-3363288-A1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR SPHAEROCARPUS | Curearth, Inc. (KR) | 2018-08-22 | — | — | EP | disclosed |
| WO-2017065401-A1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR SPHAEROCARPUS | 주식회사 큐얼스 | 2017-04-20 | — | — | WO | disclosed |
| US-6689772-B1 | ANTINEOPLASTIC AGENTS; OSTEOPOROSIS; POLYCYSTIC KIDNEY DISEASE; ANTIVIRAL AGENTS | WYETH | 2004-02-10 | — | — | US | disclosed |
| US-4088766-A | PRODUCTION OF PROSTAGLANDINS IN MAMMALS | THE UPJOHN COMPANY (US) | 1978-05-09 | — | — | US | disclosed |
| US-4001256-A | PROSTAGLANDIN PRODUCTION IN MAMMALS | THE UPJOHN COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180271091-A1 | COMPOSITION FOR DESTRUCTION OF MICROALGAE OR SPHAEROCARPUS | TK1, TRHDE, TK2 | CYP1A2 4399/4885CYP2D6 4332/4885ALDH1A1 4461/4885 |
| US-11044909-B2 | Composition for destruction of microalgae or sphaerocarpus | TK1, TRHDE, TK2 | CYP1A2 4399/4885CYP2D6 4332/4885ALDH1A1 4461/4885 |
| US-20230210840-A1 | BACTERIAL NITRIC OXIDE SYNTHASE INHIBITORS | NOS1, NOS2, NOS3 | CYP1A2 297/4885CYP2D6 464/4885ALDH1A1 2101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.